Bogart Wealth LLC lowered its stake in MetLife, Inc. (NYSE:MET – Free Report) by 1.7% during the fourth quarter, Holdings Channel reports. The firm owned 79,420 shares of the financial services provider’s stock after selling 1,395 shares during the period. Bogart Wealth LLC’s holdings in MetLife were worth $6,503,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Avestar Capital LLC increased its holdings in MetLife by 9.4% in the 4th quarter. Avestar Capital LLC now owns 4,664 shares of the financial services provider’s stock valued at $382,000 after buying an additional 400 shares during the period. Values First Advisors Inc. bought a new stake in shares of MetLife during the 4th quarter worth approximately $36,000. Avidian Wealth Enterprises LLC increased its stake in MetLife by 7.6% in the fourth quarter. Avidian Wealth Enterprises LLC now owns 5,197 shares of the financial services provider’s stock valued at $426,000 after acquiring an additional 367 shares during the last quarter. Stonebridge Financial Group LLC acquired a new position in MetLife during the fourth quarter valued at approximately $75,000. Finally, Summit Trail Advisors LLC lifted its stake in MetLife by 17.1% during the fourth quarter. Summit Trail Advisors LLC now owns 12,558 shares of the financial services provider’s stock worth $1,028,000 after purchasing an additional 1,830 shares during the last quarter. Institutional investors and hedge funds own 94.99% of the company’s stock.
MetLife Price Performance
MET stock opened at $82.41 on Friday. The company has a market capitalization of $57.06 billion, a P/E ratio of 13.80, a PEG ratio of 0.64 and a beta of 1.07. The company has a fifty day moving average price of $83.54 and a 200-day moving average price of $81.00. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16. MetLife, Inc. has a 52-week low of $67.30 and a 52-week high of $89.05.
MetLife Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be issued a $0.545 dividend. This represents a $2.18 annualized dividend and a yield of 2.65%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife’s payout ratio is presently 36.52%.
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on the company. StockNews.com lowered MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. JPMorgan Chase & Co. lifted their target price on MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Keefe, Bruyette & Woods dropped their target price on shares of MetLife from $100.00 to $98.00 and set an “outperform” rating for the company in a report on Wednesday. BMO Capital Markets started coverage on shares of MetLife in a report on Thursday, January 23rd. They set a “market perform” rating and a $97.00 price target on the stock. Finally, Wells Fargo & Company dropped their price objective on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a research note on Tuesday, January 14th. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat, MetLife has a consensus rating of “Moderate Buy” and a consensus target price of $92.17.
Check Out Our Latest Analysis on MET
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- What is Put Option Volume?
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- The Significance of Brokerage Rankings in Stock Selection
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- How to trade using analyst ratings
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.